Figure 5.

Feature selection for predicting disease severity assessed with (A) laboratory findings or (B) clinical criteria in Dubai dataset. ACE-I, angiotensin-converting-enzyme inhibitors; ALP, alkaline phosphatase; ARB, angiotensin-II receptor blockers; ARDS, acute respiratory distress syndrome; BMI, body mass index; CRP, C-reactive protein; D.bilirubin, direct bilirubin; G6PDH, glucose-6-phosphate dehydrogenase; GCS, Glasgow coma scale; GI, gastrointestinal; HGB, hemoglobin; HCT, hematocrit; ICU, intensive care unit; IRF, immature reticulocyte fraction; LDH, lactate dehydrogenase; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin level; MCHC, mean corpuscular hemoglobin concentration; MPV, mean platelet volume; RBC, red blood cells; RDW-CV, red blood cell distribution width; SpO2, oxygen saturation; SOFA, sequential organ failure assessment; T. bilirubin, total bilirubin; T. protein, total protein; WBC, white blood cells.